CS
Cannell & Spears Portfolio holdings
AUM
$4.95B
This Quarter Return
+1.22%
1 Year Return
+21.47%
3 Year Return
+82.49%
5 Year Return
+137.04%
10 Year Return
+287.57%
AUM
$821M
AUM Growth
+$821M
(-1.8%)
Cap. Flow
-$7.99M
Cap. Flow
% of AUM
-0.97%
Top 10 Holdings %
Top 10 Hldgs %
44.69%
Holding
183
New
30
Increased
32
Reduced
45
Closed
3
Top Buys
| 1 |
DLPH
Delphi Technologies PLC Ordinary Shares
DLPH
|
$7.01M |
| 2 |
VanEck Oil Services ETF
OIH
|
$1.51M |
| 3 |
Johnson & Johnson
JNJ
|
$1.29M |
| 4 |
PepsiCo
PEP
|
$1.26M |
| 5 |
FMC
FMC
|
$1.14M |
Top Sells
| 1 |
Fortive
FTV
|
$10.5M |
| 2 |
GE Aerospace
GE
|
$6.48M |
| 3 |
Schlumberger
SLB
|
$5.61M |
| 4 |
Brighthouse Financial
BHF
|
$2.37M |
| 5 |
AGN
Allergan plc
AGN
|
$1.39M |
Sector Composition
| 1 | Financials | 25.82% |
| 2 | Healthcare | 18.07% |
| 3 | Technology | 15.06% |
| 4 | Consumer Discretionary | 12.11% |
| 5 | Communication Services | 10.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Johnson & Johnson
JNJ
$428B
| $8.47M | 1.03% |
60,647
+9,248
| +18% | +$1.29M |
|
|
RDS.B
27
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $7.13M | 0.87% |
104,350
+800
| +0.8% | +$54.6K |
|
|
DLPH
28
DELISTED
Delphi Technologies PLC Ordinary Shares
DLPH
| $7.01M | 0.85% |
+133,548
| New | +$7.01M |
|
|
RDS.A
29
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $6.38M | 0.78% |
95,701
-1,000
| -1% | -$66.7K |
|
30
UnitedHealth
UNH
$282B
| $5.63M | 0.69% |
25,541
-813
| -3% | -$179K |
|
31
AXIS Capital
AXS
$7.67B
| $3.52M | 0.43% |
70,079
-1,335
| -2% | -$67.1K |
|
32
Adient
ADNT
$1.97B
| $3.5M | 0.43% |
44,475
-384
| -0.9% | -$30.2K |
|
33
SPDR S&P 500 ETF Trust
SPY
$648B
| $3.13M | 0.38% |
11,722
-2,345
| -17% | -$626K |
|
34
Union Bankshares
UNB
$118M
| $2.97M | 0.36% |
56,102
-3,255
| -5% | -$172K |
|
35
Berkshire Hathaway Class B
BRK.B
$1.08T
| $2.83M | 0.34% |
14,274
+150
| +1% | +$29.7K |
|
36
Aon
AON
$79.5B
| $2.69M | 0.33% |
20,041
| – | – |
|
37
Johnson Controls International
JCI
$69B
| $2.46M | 0.3% |
64,531
-1,938
| -3% | -$73.8K |
|
38
Exxon Mobil
XOM
$489B
| $2.29M | 0.28% |
27,377
-6,746
| -20% | -$564K |
|
|
39
PepsiCo
PEP
$208B
| $2.12M | 0.26% |
17,709
+10,475
| +145% | +$1.26M |
|
40
Wells Fargo
WFC
$260B
| $2.11M | 0.26% |
34,726
+2,091
| +6% | +$127K |
|
41
Trimble
TRMB
$18.6B
| $2.06M | 0.25% |
50,600
-1,400
| -3% | -$56.9K |
|
42
Vanguard Small-Cap Value ETF
VBR
$31B
| $1.96M | 0.24% |
14,770
+825
| +6% | +$110K |
|
43
Biogen
BIIB
$20.1B
| $1.71M | 0.21% |
5,376
-1,739
| -24% | -$554K |
|
44
iShares Biotechnology ETF
IBB
$5.65B
| $1.66M | 0.2% |
15,564
+10,456
| +205% | +$1.12M |
|
45
Merck
MRK
$213B
| $1.53M | 0.19% |
27,166
| – | – |
|
|
46
VanEck Oil Services ETF
OIH
$875M
| $1.51M | 0.18% |
+58,050
| New | +$1.51M |
|
47
Procter & Gamble
PG
$372B
| $1.5M | 0.18% |
16,353
-3,895
| -19% | -$358K |
|
48
Kinder Morgan
KMI
$59.3B
| $1.5M | 0.18% |
82,841
+6,100
| +8% | +$110K |
|
|
49
Berkshire Hathaway Class A
BRK.A
$1.08T
| $1.49M | 0.18% |
5
| – | – |
|
50
IBM
IBM
$223B
| $1.35M | 0.16% |
8,817
+300
| +4% | +$46K |
|